unknown
Stage
1
Investors
About
Developing a new antiviral molecule intended to treat influenza (an anti‑flu therapeutic).
Explore AIS Biotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Developing a new antiviral molecule intended to treat influenza (an anti‑flu therapeutic).
Funding rounds, investor list, and risk signals — unlock with a subscription.